• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坚持采用停止高血压的饮食方法(DASH)与新发 1 型糖尿病和 2 型糖尿病患者的内脏和肝脏脂肪含量较低有关。

Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet is associated with lower visceral and hepatic lipid content in recent-onset type 1 diabetes and type 2 diabetes.

机构信息

Institute for Biometrics and Epidemiology, German Diabetes Centre, Leibniz Centre for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

German Centre for Diabetes Research (DZD), Partner Düsseldorf, Neuherberg, Germany.

出版信息

Diabetes Obes Metab. 2024 Oct;26(10):4281-4292. doi: 10.1111/dom.15772. Epub 2024 Jul 15.

DOI:10.1111/dom.15772
PMID:39010284
Abstract

AIM

To investigate the associations of the Dietary Approaches to Stop Hypertension (DASH) score with subcutaneous (SAT) and visceral (VAT) adipose tissue volume and hepatic lipid content (HLC) in people with diabetes and to examine whether changes in the DASH diet were associated with changes in these outcomes.

METHODS

In total, 335 participants with recent-onset type 1 diabetes (T1D) and type 2 diabetes (T2D) from the German Diabetes Study were included in the cross-sectional analysis, and 111 participants in the analysis of changes during the 5-year follow-up. Associations between the DASH score and VAT, SAT and HLC and their changes were investigated using multivariable linear regression models by diabetes type. The proportion mediated by changes in potential mediators was determined using mediation analysis.

RESULTS

A higher baseline DASH score was associated with lower HLC, especially in people with T2D (per 5 points: -1.5% [-2.7%; -0.3%]). Over 5 years, a 5-point increase in the DASH score was associated with decreased VAT in people with T2D (-514 [-800; -228] cm). Similar, but imprecise, associations were observed for VAT changes in people with T1D (-403 [-861; 55] cm) and for HLC in people with T2D (-1.3% [-2.8%; 0.3%]). Body mass index and waist circumference changes explained 8%-48% of the associations between DASH and VAT changes in both groups. In people with T2D, adipose tissue insulin resistance index (Adipo-IR) changes explained 47% of the association between DASH and HLC changes.

CONCLUSIONS

A shift to a DASH-like diet was associated with favourable VAT and HLC changes, which were partly explained by changes in anthropometric measures and Adipo-IR.

摘要

目的

探讨膳食方法阻止高血压(DASH)评分与糖尿病患者皮下(SAT)和内脏(VAT)脂肪组织体积和肝脂含量(HLC)的相关性,并研究 DASH 饮食的变化是否与这些结果的变化相关。

方法

共有 335 名新发 1 型糖尿病(T1D)和 2 型糖尿病(T2D)患者参与了横断面分析,111 名患者参与了 5 年随访期间的变化分析。采用多元线性回归模型,按糖尿病类型分析 DASH 评分与 VAT、SAT 和 HLC 及其变化之间的关系。采用中介分析确定潜在中介因素变化的介导比例。

结果

基线 DASH 评分较高与 HLC 水平较低相关,尤其是在 T2D 患者中(每增加 5 分:-1.5%[-2.7%;-0.3%])。在 5 年内,DASH 评分增加 5 分与 T2D 患者的 VAT 减少相关(-514[-800;-228]cm)。T1D 患者的 VAT 变化(-403[-861;55]cm)和 T2D 患者的 HLC 变化(-1.3%[-2.8%;0.3%])也观察到类似但不精确的相关性。在两组患者中,DASH 与 VAT 变化之间的相关性,体重指数和腰围变化解释了 8%-48%。在 T2D 患者中,脂肪组织胰岛素抵抗指数(Adipo-IR)变化解释了 DASH 与 HLC 变化之间相关性的 47%。

结论

向 DASH 饮食的转变与有利的 VAT 和 HLC 变化相关,这些变化部分由人体测量指标和 Adipo-IR 的变化所解释。

相似文献

1
Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet is associated with lower visceral and hepatic lipid content in recent-onset type 1 diabetes and type 2 diabetes.坚持采用停止高血压的饮食方法(DASH)与新发 1 型糖尿病和 2 型糖尿病患者的内脏和肝脏脂肪含量较低有关。
Diabetes Obes Metab. 2024 Oct;26(10):4281-4292. doi: 10.1111/dom.15772. Epub 2024 Jul 15.
2
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
3
Unraveling adipose tissue proteomic landscapes in severe obesity: insights into metabolic complications and potential biomarkers.解析严重肥胖症中脂肪组织蛋白质组学图谱:代谢并发症与潜在生物标志物研究进展。
Am J Physiol Endocrinol Metab. 2023 Nov 1;325(5):E562-E580. doi: 10.1152/ajpendo.00153.2023. Epub 2023 Oct 4.
4
Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes.预测 2 型糖尿病的血清脂肪因子在皮下和内脏脂肪组织中的基因表达。
Obesity (Silver Spring). 2010 May;18(5):884-9. doi: 10.1038/oby.2009.443. Epub 2009 Dec 17.
5
Adherence to dietary approaches to stop hypertension diet and visceral adipose tissue area among U.S. adults, a cross-sectional study.美国成年人中遵循停止高血压饮食法和内脏脂肪面积的研究。
Int J Food Sci Nutr. 2024 Nov;75(7):729-737. doi: 10.1080/09637486.2024.2397061. Epub 2024 Aug 29.
6
Insulin resistance, hepatic lipid and adipose tissue distribution in HIV-infected men.HIV感染男性的胰岛素抵抗、肝脏脂质与脂肪组织分布
Antivir Ther. 2008;13(3):423-8.
7
Subcutaneous and visceral adipose tissue FTO gene expression and adiposity, insulin action, glucose metabolism, and inflammatory adipokines in type 2 diabetes mellitus and in health.2 型糖尿病与健康人群中皮下和内脏脂肪组织 FTO 基因表达与肥胖、胰岛素作用、葡萄糖代谢和炎症性脂肪因子的关系。
Obes Surg. 2010 Jan;20(1):108-13. doi: 10.1007/s11695-009-9952-1. Epub 2009 Sep 9.
8
Visceral adipose tissue is more strongly associated with insulin resistance than subcutaneous adipose tissue in Chinese subjects with pre-diabetes.在患有糖尿病前期的中国受试者中,内脏脂肪组织比皮下脂肪组织与胰岛素抵抗的关联更强。
Curr Med Res Opin. 2018 Jan;34(1):123-129. doi: 10.1080/03007995.2017.1364226. Epub 2017 Aug 31.
9
Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes.2型糖尿病患者腹部内脏脂肪及皮下脂肪组织与脂蛋白颗粒数量和大小的关系
Diabetes. 2008 Aug;57(8):2022-7. doi: 10.2337/db08-0157. Epub 2008 May 9.
10
Stricter Adherence to Dietary Approaches to Stop Hypertension (DASH) and its Association with Lower Blood Pressure, Visceral Fat, and Waist Circumference in University Students.更严格地遵循停止高血压的饮食方法(DASH)及其与大学生血压、内脏脂肪和腰围降低的关系。
Nutrients. 2020 Mar 11;12(3):740. doi: 10.3390/nu12030740.

引用本文的文献

1
Global regional, and national burden of type 2 diabetes attributable to dietary factors from 1990 to 2021.1990年至2021年全球、区域和国家层面归因于饮食因素的2型糖尿病负担
Sci Rep. 2025 Apr 17;15(1):13278. doi: 10.1038/s41598-025-98022-y.